No Data
No Data
Amoy Diagnostics (300685.SZ) obtained a medical device registration certificate.
Amoy Diagnostics (300685.SZ) announced that the company recently received the Medical...
Amoy Diagnostics (300685.SZ): The FGFR2 gene break detection kit (fluorescence in situ hybridization method) has been approved for listing in Japan.
amoy diagnostics (300685.SZ) announced that the company's self-developed FGFR2 gene breakpoint detection kit...
Amoy Diagnostics (300685.SZ): has repurchased 0.94% of shares.
On September 2, Gelonghui announced that Amoy Diagnostics (300685.SZ) disclosed that, as of August 31, 2024, the company had repurchased 3,752,740 shares through a repurchase special securities account for centralized competitive bidding trading, accounting for 0.94% of the company's current total share capital. The highest fill price for the repurchased shares was 21.91 yuan/share, and the lowest fill price was 17.20 yuan/share, with a total amount paid of 69,458,513.60 yuan (excluding transaction costs). This repurchase complies with the company's established share repurchase program and relevant laws and regulations.
In the Wake of Amoy Diagnostics Co., Ltd.'s (SZSE:300685) Latest CN¥383m Market Cap Drop, Institutional Owners May Be Forced to Take Severe Actions
Currently, Amoy Diagnostics (300685.SZ) has no testing products related to monkeypox virus.
Amoy Diagnostics (300685.SZ) stated on the investor interaction platform on August 21 that the company currently does not have any monkeypox virus-related detection products.
Amoy Diagnostics (300685.SZ): Has repurchased 0.79% of shares.
Amoy Diagnostics (300685.SZ) announced that as of July 31, 2024, the company has repurchased 3,147,440 shares of its own stock through a repurchase special securities account with a centralized trading method. The repurchased shares accounted for 0.79% of the company's total share capital. The highest fill price for repurchased shares was 21.91 yuan/share, and the lowest fill price was 17.20 yuan/share. The total amount paid was 58.7648 million yuan (excluding transaction fees).
No Data